论文部分内容阅读
目的:探讨孟鲁司特钠联合匹多莫德治疗咳嗽变异性哮喘的效果,为咳嗽变异性哮喘患者临床有效治疗提供重要依据。方法:选取2013年5月至2014年8月我院收治的咳嗽变异性哮喘患者110例,随机分成观察组和对照组两组,对照组患者通过服用适量的酮替芬和硫酸沙进行治疗,而观察组患者则进行孟鲁司特钠联合匹多莫德治疗,观察两组患者的治疗效果。结果:经过观察对比,观察组患者的治疗有效率明显比对照组要高,病情复发率明显比对照组要低,且不良反应出现人数比对照组少,差异存在统计学意义(P<0.05)。结论:孟鲁司特钠联合匹多莫德治疗咳嗽变异性哮喘患者的效果是比较明显的,且可以大大降低患者病情复发率,效果显著,值得临床推广。
Objective: To investigate the effect of montelukast sodium combined with pidotimod in the treatment of cough variant asthma, and to provide an important basis for the clinical effective treatment of cough variant asthma patients. Methods: A total of 110 cough variant asthma patients admitted to our hospital from May 2013 to August 2014 were randomly divided into two groups: observation group and control group. Patients in the control group were treated with ketotifen and sulfate, Patients in the observation group were treated with montelukast sodium and pidotimod, and the therapeutic effect was observed in both groups. Results: After observation and comparison, the effective rate of observation group was significantly higher than that of control group. The recurrence rate was significantly lower than that of control group, and the number of adverse reactions was less than that of control group. The difference was statistically significant (P <0.05) . Conclusion: Montelukast combined with pidotimod in the treatment of patients with cough variant asthma is more obvious, and can greatly reduce the patient’s recurrence rate, the effect is significant, worthy of clinical promotion.